Search research articles
Contact Us
Filters
Showing results (191-200 of 326) with videos related to
Page
of 33
Sort By:
Clinical and Molecular Hepatology
|
May 11, 2022
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, et al.
Plos One
|
March 6, 2012
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B
Wai-Kay Seto, Ching-Lung Lai, Philip P C Ip, et al.
Digestive Diseases and Sciences
|
May 10, 2020
Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Man-Fung Yuen, Sze-Hang Liu, Wai-Kay Seto, et al.
Plos One
|
August 24, 2012
High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B
Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
The Lancet. Global Health
|
January 22, 2022
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
Shu Su, William Cw Wong, Zhuoru Zou, et al.
Clinical and Translational Gastroenterology
|
October 27, 2017
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Yuk-Fai Lam, Wai-Kay Seto, Danny Wong, et al.
JHEP Reports : Innovation in Hepatology
|
January 8, 2026
Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis
Lu Li, Xianhua Mao, Chi Ho Lee, et al.
Helicobacter
|
September 8, 2024
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Ka Shing Cheung, Tao Lyu, Zijie Deng, et al.
JHEP Reports : Innovation in Hepatology
|
September 7, 2023
Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
Rui Li, Mingwang Shen, Jason J Ong, et al.
Frontiers in Microbiology
|
March 14, 2022
Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction
Saisai Zhang, Hein M Tun, Dengwei Zhang, et al.
Page
of 33
Search research articles
Search
Showing results (191-200 of 326) with videos related to
Sort By:
Page
of 33
Clinical and Molecular Hepatology
|
May 11, 2022
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, et al.
Plos One
|
March 6, 2012
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B
Wai-Kay Seto, Ching-Lung Lai, Philip P C Ip, et al.
Digestive Diseases and Sciences
|
May 10, 2020
Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Man-Fung Yuen, Sze-Hang Liu, Wai-Kay Seto, et al.
Plos One
|
August 24, 2012
High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B
Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
The Lancet. Global Health
|
January 22, 2022
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
Shu Su, William Cw Wong, Zhuoru Zou, et al.
Clinical and Translational Gastroenterology
|
October 27, 2017
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Yuk-Fai Lam, Wai-Kay Seto, Danny Wong, et al.
JHEP Reports : Innovation in Hepatology
|
January 8, 2026
Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis
Lu Li, Xianhua Mao, Chi Ho Lee, et al.
Helicobacter
|
September 8, 2024
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Ka Shing Cheung, Tao Lyu, Zijie Deng, et al.
JHEP Reports : Innovation in Hepatology
|
September 7, 2023
Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies
Rui Li, Mingwang Shen, Jason J Ong, et al.
Frontiers in Microbiology
|
March 14, 2022
Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction
Saisai Zhang, Hein M Tun, Dengwei Zhang, et al.
Page
of 33